These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7869214)
41. Clinical inquiries: can recombinant growth hormone effectively treat idiopathic short stature? Von Fange T; McDiarmid T; Mackler L; Zolotor A J Fam Pract; 2008 Sep; 57(9):611-2. PubMed ID: 18786336 [TBL] [Abstract][Full Text] [Related]
42. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone. Westphal O; Lindberg A; Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357 [TBL] [Abstract][Full Text] [Related]
43. [The model of height prognosis in children with growth hormone deficiency]. Kostecka L; Wasikowa R; NoczyĆska A; Filipowski H Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):113-7. PubMed ID: 15504314 [TBL] [Abstract][Full Text] [Related]
44. Growth and puberty after growth hormone treatment after irradiation for brain tumours. Ogilvy-Stuart AL; Shalet SM Arch Dis Child; 1995 Aug; 73(2):141-6. PubMed ID: 7574858 [TBL] [Abstract][Full Text] [Related]
45. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. Mauras N; Gonzalez de Pijem L; Hsiang HY; Desrosiers P; Rapaport R; Schwartz ID; Klein KO; Singh RJ; Miyamoto A; Bishop K J Clin Endocrinol Metab; 2008 Mar; 93(3):823-31. PubMed ID: 18165285 [TBL] [Abstract][Full Text] [Related]
46. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age. Cutfield WS; Jackson WE; Jefferies C; Robinson EM; Breier BH; Richards GE; Hofman PL J Pediatr; 2003 Feb; 142(2):113-6. PubMed ID: 12584529 [TBL] [Abstract][Full Text] [Related]
47. Final height of short normal children treated with growth hormone. Hindmarsh PC; Brook CG Lancet; 1996 Jul; 348(9019):13-6. PubMed ID: 8691923 [TBL] [Abstract][Full Text] [Related]
48. Growth hormone therapy in children after cranial/craniospinal radiation therapy: sexually dimorphic outcomes. Lerner SE; Huang GJ; McMahon D; Sklar CA; Oberfield SE J Clin Endocrinol Metab; 2004 Dec; 89(12):6100-4. PubMed ID: 15579765 [TBL] [Abstract][Full Text] [Related]
49. Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children. de Waal WJ; Greyn-Fokker MH; Stijnen T; van Gurp EA; Toolens AM; de Munick Keizer-Schrama SM; Aarsen RS; Drop SL J Clin Endocrinol Metab; 1996 Mar; 81(3):1206-16. PubMed ID: 8772601 [TBL] [Abstract][Full Text] [Related]
50. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone. Balducci R; Toscano V; Mangiantini A; Municchi G; Vaccaro F; Picone S; Di Rito A; Boscherini B J Clin Endocrinol Metab; 1995 Dec; 80(12):3596-600. PubMed ID: 8530605 [TBL] [Abstract][Full Text] [Related]
51. Growth hormone therapy with three dosage regimens in children with idiopathic short stature. European Study Group Participating Investigators. Rekers-Mombarg LT; Massa GG; Wit JM; Matranga AM; Buckler JM; Butenandt O; Chaussain JL; Frisch H; Leiberman E; Yturriaga R; Aarskog D; Chatelain PG; Colle M; Dacou-Voutetakis C; Delemarre-van de Waal HA; Girard F; Gosen JJ; Irle U; Jansen M; Jean R; Job JC; Kaar ML; Kollemann F; Lenko HL; Waelkens JJ J Pediatr; 1998 Mar; 132(3 Pt 1):455-60. PubMed ID: 9544901 [TBL] [Abstract][Full Text] [Related]
52. Testosterone treatment in adolescent boys with constitutional delay in growth and development. Richman RA; Kirsch LR N Engl J Med; 1988 Dec; 319(24):1563-7. PubMed ID: 3200264 [TBL] [Abstract][Full Text] [Related]
53. The effect of gonadotrophin releasing hormone analogue on height prognosis in growth hormone deficiency and normal puberty. Stanhope R; Brook CG Eur J Pediatr; 1988 Dec; 148(3):200-2. PubMed ID: 3145878 [TBL] [Abstract][Full Text] [Related]
54. Growth hormone measurements versus auxology in treatment decisions: the Australian experience. Werther GA J Pediatr; 1996 May; 128(5 Pt 2):S47-51. PubMed ID: 8627470 [TBL] [Abstract][Full Text] [Related]
55. Biosynthetic human growth hormone in three children with short stature. Murphy E; Gill D Ir Med J; 1990 Mar; 83(1):27-8. PubMed ID: 2361836 [TBL] [Abstract][Full Text] [Related]
57. The effect of short-term growth hormone or low-dose oxandrolone treatment in boys with constitutional growth delay. Loche S; Pintor C; Cambiaso P; Lampis A; Carta D; Corda R; Cappa M J Endocrinol Invest; 1991 Oct; 14(9):747-50. PubMed ID: 1761810 [TBL] [Abstract][Full Text] [Related]
58. Growth hormone treatment and the short child: to treat or not to treat? Bercu BB J Pediatr; 1987 Jun; 110(6):991-5. PubMed ID: 3295165 [No Abstract] [Full Text] [Related]
59. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. Wit JM; Rekers-Mombarg LT; Cutler GB; Crowe B; Beck TJ; Roberts K; Gill A; Chaussain JL; Frisch H; Yturriaga R; Attanasio AF J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821 [TBL] [Abstract][Full Text] [Related]
60. Human growth hormone and gonadotropin releasing hormone analog combination therapy increases predicted height in short normal girls. Maniati-Christidi M; Livadas S; Voutetakis A; Tolis G; Dacou-Voutetakis C Clin Pediatr (Phila); 2003; 42(1):59-65. PubMed ID: 12635983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]